Teva Investigational Site 12223 — Omaha, Nebraska

Teva Investigational Site 12223 is a clinical research site located in Omaha, Nebraska, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Teva Investigational Site 12223 has participated in 1 clinical trials.

Therapeutic areas: Osteoarthritis of the Knee.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 12223?

Teva Investigational Site 12223 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 12223 conducted?

Teva Investigational Site 12223 has 1 clinical trials on record. Their work covers Osteoarthritis of the Knee.

Is Teva Investigational Site 12223 accredited by Crixeo Health?

Teva Investigational Site 12223 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 12223?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.